While there is a wide variation among women of follicular phase lengths, it is generally accepted that a «normal» luteal phase is approximately 14 days. (ovagraph.com)
The combination of rituximab (Rituxan) and the novel immunotherapy pidilizumab (CT - 011) is both active and well tolerated in follicular lymphoma patients, according to results of a phase II trial presented by Jason R. Westin, MD, of the MD Anderson Cancer Center in Houston, at the American Society of Hematology (ASH) meeting in Atlanta. (cancernetwork.com)
«There are currently many exciting therapies including conventional chemotherapies, small molecule inhibitor tyrosine kinase inhibitors and immune modulating therapies under development in follicular lymphoma,» Westin told Cancer Network. (cancernetwork.com)